CA2271770A1 - Method for detection of metastatic prostate cancer - Google Patents

Method for detection of metastatic prostate cancer Download PDF

Info

Publication number
CA2271770A1
CA2271770A1 CA002271770A CA2271770A CA2271770A1 CA 2271770 A1 CA2271770 A1 CA 2271770A1 CA 002271770 A CA002271770 A CA 002271770A CA 2271770 A CA2271770 A CA 2271770A CA 2271770 A1 CA2271770 A1 CA 2271770A1
Authority
CA
Canada
Prior art keywords
dna
oligonucleotide
amount
seq
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002271770A
Other languages
English (en)
French (fr)
Inventor
Donald J. Tindall
Charles Y. F. Young
Daniel J. Mccormick
George G. Klee
Mohammad Saeed Saedi
Abhay Kumar
Harry G. Rittenhouse
Robert L. Wolfert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Mayo Foundation for Medical Education and Research
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2271770A1 publication Critical patent/CA2271770A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002271770A 1996-11-14 1997-11-14 Method for detection of metastatic prostate cancer Abandoned CA2271770A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75935496A 1996-11-14 1996-11-14
US08/759,354 1996-11-14
PCT/US1997/020948 WO1998021365A2 (en) 1996-11-14 1997-11-14 Method for detection of metastatic prostate cancer

Publications (1)

Publication Number Publication Date
CA2271770A1 true CA2271770A1 (en) 1998-05-22

Family

ID=25055346

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002271770A Abandoned CA2271770A1 (en) 1996-11-14 1997-11-14 Method for detection of metastatic prostate cancer

Country Status (6)

Country Link
EP (1) EP0941368A2 (zh)
JP (1) JP2001503991A (zh)
CN (1) CN1238013A (zh)
AU (1) AU737659B2 (zh)
CA (1) CA2271770A1 (zh)
WO (1) WO1998021365A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767587B2 (en) 1999-01-28 2003-11-20 Gen-Probe Incorporated Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
FI990382A0 (fi) * 1999-02-23 1999-02-23 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
US8663600B2 (en) 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
FR2906537A1 (fr) * 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
JP6101274B2 (ja) 2011-10-28 2017-03-22 フレダックス・アクチエボラーグ 治療剤およびその使用
RU2687163C1 (ru) 2013-11-19 2019-05-07 Фредакс Аб Полипептиды антител и их применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502889A (ja) * 1992-10-29 1996-04-02 トーマス・ジェファーソン・ユニバーシティ 前立腺癌の微小転移を検出する方法
CA2187775A1 (en) * 1994-04-15 1995-10-26 Aaron E. Katz Method for molecular staging of prostate cancer
EP0804593A1 (en) * 1994-05-10 1997-11-05 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide
AU4897896A (en) * 1995-01-04 1996-07-24 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
ATE317435T1 (de) * 1995-02-24 2006-02-15 Sloan Kettering Inst Cancer Prostataspezifisches membranes antigen und seine anwendungen

Also Published As

Publication number Publication date
WO1998021365A3 (en) 1998-10-15
JP2001503991A (ja) 2001-03-27
WO1998021365A2 (en) 1998-05-22
EP0941368A2 (en) 1999-09-15
AU5260298A (en) 1998-06-03
AU737659B2 (en) 2001-08-23
CN1238013A (zh) 1999-12-08

Similar Documents

Publication Publication Date Title
US6479263B1 (en) Method for detection of micrometastatic prostate cancer
JP4205738B2 (ja) 安定ｈｋ２ポリペプチド変異体
EP0948630B1 (en) Cloning and characterization of napsin, an aspartic protease
WO1995030758A9 (en) Recombinant hk2 polypeptide
WO1995030758A1 (en) Recombinant hk2 polypeptide
US6482599B1 (en) Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
WO1998059073A1 (en) Method for detection of breast cancer
AU739546B2 (en) Forms of prostate specific antigen and methods for their detection
AU737659B2 (en) Method for detection of metastatic prostate cancer
EP0974057B1 (en) Methods to detect hk2 polypeptides
WO1998002748A9 (en) Methods to detect hk2 polypeptides
EP1392719B1 (en) Forms of prostate specific antigens and methods for their detection
JP2002538818A (ja) 前立腺腫瘍組織におけるヒトカリクレイン２とプロテアーゼインヒビター−６の新規な複合体および該複合体の利用方法
US20040259113A1 (en) Method for detection of metastatic prostate cancer
MXPA99004504A (en) Method for detection of metastatic prostate cancer
MXPA99000659A (es) Metodos para detectar polipeptidos de hk2

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued